| 42/74 | US=4 / Câncer Lee MLM, Pasqualotto GC. Leucemias na infância. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 543-53. ISBN 85-3631168-5. |
| 43/74 | US=4 / Câncer Pereira WV. Leucemia mielóide aguda. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 683-96. ISBN 85-3631168-5. LEUCEMIA MIELOIDE AGUDA. DIAGNOSTICO; LEUCEMIA MIELOIDE AGUDA. PATOLOGIA; LEUCEMIA MIELOIDE AGUDA. ESTADIAMENTO; LEUCEMIA MIELOIDE AGUDA. FATORES DE RISCO; LEUCEMIA MIELOIDE AGUDA. PROGNOSTICO; LEUCEMIA MIELOIDE AGUDA. TRATAMENTO |
| 44/74 | US=69 / Câncer Estey E. Targeted therapy in acute myelogenous leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 21-42. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; TERAPIA-ALVO NA LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE AGUDA; ATRA E ARSENICO TRIOXIDO OZOGAMICINA; FLT-3 INIBIDORES; INIBIDORES DA FARNESIL TRANSFERASE; EPIGENETICA AGENTES DE ACAO |
| 45/74 | US=58 / Câncer Friedenson B. The BRCA1/2 pathway prevents some leukemias and lymphomas in addition to breast/ovarian cancers: malignancies that overcome checkpoint controls. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 155-68. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. BRCA1; BRCA2; REPARACAO DO ADN; LEUCEMIAS; LINFOMAS; LINFOMA DE CELULAS DO MANTO; LEUCEMIA MIELOIDE AGUDA |
| 46/74 | US=8 / Câncer Melo M. Leucemias agudas. In: ___. Leucemias & linfomas altas do sangue periférico. São Paulo: Livraria Médica Paulista, 2008. p. 1-42. ISBN 85-99305-23-2. LEUCEMIAS AGUDAS; LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MISTA; LEUCEMIA BIFENOTIPICA AGUDA; LEUCEMIA MIELOIDE AGUDA. MIELOBLASTICA COM MATURACAO; LEUCEMIA MIELOIDE AGUDA. PROMIELOCITICA HIPERGRANULAR; LEUCEMIA MIELOIDE AGUDA. PROMIELOCITICA HIPOGRANULAR; LEUCEMIA MIELOIDE AGUDA. MIELOMONOCITICA COM EOSINOFILIA; LEUCEMIA MIELOIDE AGUDA. ERITROLEUCEMIA; LEUCEMIA MIELOIDE AGUDA. MEGACARIOBLASTICA |
| 47/74 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 48/74 | US=111 / Câncer Chang KL, Weiss LM. Blood and bone marrow: myeloid leukaemias and related neoplasms. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 724-32. ISBN 978-0-470-01852-1. CANCER; SANGUE; MEDULA OSSEA; LEUCEMIAS MIELOIDES; LEUCEMIA MIELOIDE AGUDA; MIELOPROLIFERATIVAS CRONICAS; SINDROMES MIELODISPLASICAS |
| 49/74 | US=35 / Câncer Ravandi F, Giles F. Overview of AML: approaching the treatment of AML from a biological perspective. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 3-23. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; REFRATARIO; CLORETAZINE; TROXACITABINE; CLOFARABINE; MTOR; FARNESILACAO; ANTICORPOS MONOCLONAIS; AGENTES ALQUILANTES; NUCLEOSIDEOS |
| 50/74 | US=35 / Câncer Frankfurt O, Peterson LC, Gallagher R, Tallman MS. Translating biology into clinical application: APL: a classic tale of bench to bedside. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 193-228. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA PROMIELOCITICA AGUDA; LEUCEMIA MIELOIDE AGUDA; PML-RARALFA; COAGULOPATIA; ACIDO RETINOICO; TRIOXIDO ARSENICO; SINDROME DO ACIDO RETINOICO |
| 51/74 | US=35 / Câncer Sausville EA. Molecular therapeutics of AML: selected targeted approaches: emerging therapeutics for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 231-46. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; EMERGENCIAS TERAPEUTICAS; NOVOS AGENTES; TERAPIA ALVO; VACINA; SINALIZACAO VEGF; ADAFOSTINA; TRITERPENOIDES |
| 52/74 | US=35 / Câncer Levis M. Molecular therapeutics of AML: FLT3: a prototype receptor tyrosine kinase target in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 247-61. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; QUINASE; FLT3; PROGNOSTICO; INIBIDORES; CELULAS TRONCO |
| 53/74 | US=35 / Câncer Lancet JE. Molecular therapeutics of AML: farnesyl transferase inhibitors in the therapy of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 263-74. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; FARNESILACAO; INIBIDORES DE FARNESITRANSFERASE; TRANSDUCAO DE SINAL |
| 54/74 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |
| 55/74 | US=35 / Câncer Lin TL, Matsui W. Molecular therapeutics of AML: differentiation therapy in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 293-312. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TERAPIA DIFERENCIADA; SINDROME MIELODISPLASICA; FATORES DE CRESCIMENTO; CICLO CELULAR; ACIDO RETINOICO; VITAMINA D; METILACAO DO DNA; BRIOSTATINA 1 |
| 56/74 | US=35 / Câncer Bolaños-Meade J, Jones RJ. Molecular therapeutics of AML: stem cell transplantation for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 313-27. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; TRANSPLANTE DE CELULAS TRONCO; SINDROME MIELODISPLASICA; LEUCEMIA PROMIELOCITICA; TRANSPLANTE DE MEDULA OSSEA; DOENCA ENXERTO VERSUS HOSPEDEIRO |
| 57/74 | US=35 / Câncer Borrello I. Molecular therapeutics of AML: tumor vaccines in leukemia. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 329-41. (Contemporary Hematology) ISBN 978-1-58829-621-4. |
| 58/74 | US=35 / Câncer Arceci RJ. Special challenges: treatment, outcomes, and challenges of newly diagnosed AML in children and adolescents. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 345-72. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; CRIANCA; ADOLESCENTE; PREDISPOSICAO HEREDITARIA; SINDROMES FAMILIARES; INSTABILIDADE CROMOSSOMICA; METABOLISMO DA DROGA; ESTRATIFICACAO DO GRUPO DE RISCO |
| 59/74 | US=35 / Câncer Stone RM. Special challenges: AML in older adults. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 373-84. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; ADULTO; LEUCEMIA MIELOIDE AGUDA. DIAGNOSTICO; LEUCEMIA MIELOIDE AGUDA. CLASSIFICACAO; LEUCEMIA MIELOIDE AGUDA. PROGNOSTICO; LEUCEMIA MIELOIDE AGUDA. TRATAMENTO |
| 60/74 | US=35 / Câncer Gotlib J. Special challenges: dameshek smiles: molecular clues to the chronic myeloproliferative disorders unmasked. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 385-98. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; DOENCAS REUMATICAS CRONICAS; JAK2 V617F; POLICITEMIA VERA; TROMBOCITEMIA ESSENCIAL; MIELOFIBROSE IDIOPATICA; DOENCA MIELOPROLIFERATIVA |